Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Biologic therapy. Stanford University Medical Center, Stanford, CA, United States

Survival: N/R
Toxicity Grade: 4
Treatments: Biologic therapy
Country: United States
City/State/Province: Stanford, CA
Hospital: Stanford University Medical Center
Journal: Link
Date: 1/2004

Patients: This phase II study involved 36 women with advanced ovarian cancer. The median age was 57.

Treatment: The treatment involved one biological agent - an antisense oligonucleotide inhibitor of protein kinase C alpha called aprinocarsen.

Toxicity: Grade 4 toxicities included nausea and throbocytopenia.

Results: There were no responses seen on scans, but one patient had a decline in serum CA 125 levels.

Support: Support was provided by ISIS pharmaceuticals. ISIS manufactures or markets aprinocarsen.

Correspondence: Branimir I. Sikic, MD

E-mail to a Friend Email Physician More Information